| BAVARIAN NORDIC |
| Dänemark |
| Gesundheit |
| DK0015998017 / 917165 |
| BV3 (Frankfurt) |
| FRA:BV3, ETR:BV3, BV3:GR |
| - |
| https://www.bavarian-nord.. |
|
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing, and commercialization of vaccines. The company specializes in life-saving immunizations for infectious diseases, with a commercial portfolio that include..
>Volltext.. |
| 2503.5 Mio. EUR |
| 2206.14 Mio. EUR |
| 851.25 Mio. EUR |
| 238.8 Mio. EUR |
| 209.89 Mio. EUR |
| 2.72 EUR |
| 17.87 Mio. EUR |
| 105.67 Mio. EUR |
| 195.68 Mio. EUR |
| 2.3 |
| -3.53% |
| 8.2% |
| - |
| - |
| - |
| - |
| BAVARIAN NORDIC |
| 11.10.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|